Detection of Group A Streptococcus (GAS) in Oral Cavity
- Conditions
- Tonsillitis
- Registration Number
- NCT02972437
- Lead Sponsor
- Hadassah Medical Organization
- Brief Summary
The investigators intend to screen children who are suspected of having GAS tonsillitis. From each child we will take a throat culture and saliva sample to screen for molecular evidence of GAS.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- clinical evidence of GAS tonsillitis
- healthy, no chronic illness
- not a GAS carrier
Exclusion Criteria
- GAS carrier
- Active background disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method molecular detection of GAS compared to throat culture detection 3 days 3 days after taking the oral sample, the investigators will compare it to the throat culture taken at the same time.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular techniques are used to detect Group A Streptococcus in pediatric tonsillitis cases?
How does molecular detection of GAS compare to traditional throat culture methods in children with tonsillitis?
Are there specific biomarkers in saliva that correlate with GAS presence in tonsillitis patients?
What are the potential adverse events associated with molecular diagnostic testing for GAS in the oral cavity?
What is the role of GAS virulence factors in the pathogenesis of pediatric tonsillitis as studied in NCT02972437?